ロード中...
In vitro reversal of supratherapeutic rivaroxaban levels with coagulation factor concentrates
BACKGROUND: A bleeding patient undergoing therapy with new oral anticoagulants is every clinician’s nightmare as no specific reversal agent is available yet. This in vitro study investigated the effect of prothrombin complex concentrate (PCC), recombinant activated factor VII (rFVIIa) and activated...
保存先:
| 出版年: | Blood Transfus |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Edizioni SIMTI - SIMTI Servizi Srl
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5016310/ https://ncbi.nlm.nih.gov/pubmed/27177413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2016.0205-15 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|